Klinik für Kardiologie
 
Menü
 
Klinik für Kardiologie / Publikationen
 
 
Publikationen mit Erst- oder Seniorautorschaft im Jahr 2016
 
The Leipzig Prospective Drug-Eluting Balloon-Registry- Outcome of 484 Consecutive Patients Treated for Coronary In-Stent Restenosis and De Novo Lesions Using Paclitaxel-Coated Balloons.
Uhlemann M, Möbius-Winkler S, Adam J, Erbs S, Mangner N, Sandri M, Boudriot E, Woinke M, Schuler GC, Linke A
Circ J. 2016 Jan 25;80(2):379-86
 
Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction Presenting Late After Symptom Onset.
Desch S, Stiermaier T, de Waha S, Lurz P, Gutberlet M, Sandri M, Mangner N, Boudriot E, Woinke M, Erbs S, Schuler G, Fürnau G, Eitel I, Thiele H
JACC Cardiovasc Interv. 2016 Jan 25;9(2):113-22
 
Long-Term Exercise Training in Patients With Advanced Chronic Heart Failure: Sustained Benefits on Left Ventricular Performance And Exercise Capacity.
Höllriegel R, Winzer EB, Linke A, Adams V, Mangner N, Sandri M, Bowen TS, Hambrecht R, Schuler G, Erbs S.
J Cardiopulm Rehabil Prev. 2016 Mar-Apr. 36(2):117-24
 
Postsurgical complications after TAVI using first and second-generation transcatheter heart valves.
Haensig M, Holzhey DM, Mangner N, Mohr FW.
In Aortic valve surgery, ISBN 978-1-944685-94-2, 2016
 
Hemodynamic Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Implantation: The Diastolic Pressure Time Index.
Höllriegel R, Woitek F, Stativa R, Mangner N, Fuernau G, Haußig S, Holzhey D, Mohr FW, Schuler G, Linke A.
JACC Cardiovasc Interv. 2016 May 23;9(10):1061-8
 
Coronary Collateral Growth Induced by Physical Exercise: Results of the Leipzig EXerCIse Training versus mEdical management in patients with stable coronary artery disease (EXCITE) trial.
Möbius-Winkler S*, Uhlemann M*, Adams V, Sandri M, Erbs S, Lenk K, Mangner N, Mueller U, Adam J, Grunze M, Brunner S, Hilberg T, Mende M, Linke AP, Schuler G.
Circulation. 2016 Apr 12;133(15):1438-48
 
LATITUDE-TIMI 60 Investigators. Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.
O'Donoghue ML, Glaser R, Cavender MA, Aylward PE, Bonaca MP, Budaj A, Davies RY, Dellborg M, Fox KA, Gutierrez JA, Hamm C, Kiss RG, Kovar F, Kuder JF, Im KA, Lepore JJ, Lopez-Sendon JL, Ophuis TO, Parkhomenko A, Shannon JB, Spinar J, Tanguay JF, Ruda M, Steg PG, Theroux P, Wiviott SD, Laws I, Sabatine MS, Morrow DA.
JAMA. 2016 Apr 19;315(15):1591-9
 
Incidence, predictors and outcome of patients developing infective endocarditis following transfemoral transcatheter aortic valve implantation.
Mangner N, Woitek F, Haussig S, Schlotter F, Stachel G, Höllriegel R, Wilde J, Lindner A, Holzhey D, Leontyev S, Mohr FW, Schuler G, Linke A.
J Am Coll Cardiol. 2016 Jun 21;67(24):2907-8
 
Aerobic exercise training in chronic heart failure attenuates contractile dysfunction, oxidative protein modifications and proteolysis in the diaphragm.
Mangner N*, Bowen TS*, Werner S, Fischer T, Kullnick Y, Oberbach A, Linke A, Steil L, Schuler G, Adams V.
Med Sci Sports Exerc. 2016 Jun 20. [Epub ahead of print]
 
Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial.
Haussig S, Mangner N, Dwyer MG, Lehmkuhl L, Lücke C, Woitek F, Holzhey DM, Mohr FW, Gutberlet M, Zivadinov R, Schuler G, Linke A.
JAMA. 2016 Aug 9;316(6):592-601
ISSN 1
 
Skeletal Muscle Alterations Are Exacerbated in Heart Failure With Reduced Compared With Preserved Ejection Fraction: Mediated by Circulating Cytokines?
Seiler M, Bowen TS, Rolim N, Dieterlen MT, Werner S, Hoshi T, Fischer T, Mangner N, Linke A, Schuler G, Halle M, Wisloff U, Adams V.
Circ Heart Fail. 2016 Sep;9(9). pii: e003027. doi: 10.1161/CIRCHEARTFAILURE.116.003027
 
Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death.
Regueiro A, Linke A, Latib A, Ihlemann N, Urena M, Walther T, Husser O, Herrmann HC, Nombela-Franco L, Cheema AN, Le Breton H, Stortecky S, Kapadia S, Bartorelli AL, Sinning JM, Amat-Santos I, Munoz-Garcia A, Lerakis S, Gutiérrez-Ibanes E, Abdel-Wahab M, Tchetche D, Testa L, Eltchaninoff H, Livi U, Castillo JC, Jilaihawi H, Webb JG, Barbanti M, Kodali S, de Brito FS Jr, Ribeiro HB, Miceli A, Fiorina C, Dato GM, Rosato F, Serra V, Masson JB, Wijeysundera HC, Mangione JA, Ferreira MC, Lima VC, Carvalho LA, Abizaid A, Marino MA, Esteves V, Andrea JC, Giannini F, Messika-Zeitoun D, Himbert D, Kim WK, Pellegrini C, Auffret V, Nietlispach F, Pilgrim T, Durand E, Lisko J, Makkar RR, Lemos PA, Leon MB, Puri R, San Roman A, Vahanian A, S?ndergaard L, Mangner N, Rodés-Cabau J.
JAMA. 2016 Sep 13;316(10):1083-92
 
Three-Year Outcomes of Transcatheter Aortic Valve Implantation in Patients With Varying Levels of Surgical Risk (from the CoreValve ADVANCE Study).
Barbanti M, Schiltgen M, Verdoliva S, Bosmans J, Bleiziffer S, Gerckens U, Wenaweser P, Brecker S, Gulino S, Tamburino C, Linke A
Am J Cardiol 2016; 117(5): 820-827
ISSN 0002-9149
Impact factor: 3.154
 
Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy.
Besler C, Urban D, Watzka S, Lang D, Rommel KP, Kandolf R, Klingel K, Thiele H, Linke A, Schuler G, Adams V, Lurz P
Eur J Heart Fail 2016; 18(12): 1442-1451
ISSN 1388-9842
Impact factor: 5.135
 
Initial Experience With Ultra High-Density Mapping of Human Right Atria.
Bollmann A, Hilbert S, John S, Kosiuk J, Hindricks G
J Cardiovasc Electrophysiol 2016; 27(2): 154-160
ISSN 1045-3873
Impact factor: 3.097
 
Inheriting a high aerobic fitness predisposes to skeletal muscle and endothelial dysfunction in chronic heart failure.
Bowen TS, Eisenkolb S, Werner S, Schwarzer M, Schuler G, Adams V
Int J Cardiol 2016; 203: 353-356
ISSN 0167-5273
Impact factor: 4.638
 
Impact of Anesthesia Type on Outcomes of Transcatheter Aortic Valve Implantation (from the Multicenter ADVANCE Study).
Brecker SJ, Bleiziffer S, Bosmans J, Gerckens U, Tamburino C, Wenaweser P, Linke A
Am J Cardiol 2016; 117(8): 1332-1338
ISSN 0002-9149
Impact factor: 3.154
 
CardioPulse: Leipzig Heart Centre - Department of Electrophysiology.
Dagres N, Hindricks G
Eur Heart J 2016; 37(7): 581-583
ISSN 0195-668X
Impact factor: 15.064
 
Pulmonary pressure, telemedicine, and heart failure therapy.
Dagres N, Hindricks G
Lancet 2016; 387(10017): 408-410
ISSN 0140-6736
Impact factor: 44.002
 
Differences in predictors of implantable cardioverter-defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies.
Darma A, Nedios S, Kosiuk J, Richter S, Doering M, Arya A, Rolf S, Sommer P, Hindricks G, Bollmann A
Europace 2016; 18(3): 405-412
ISSN 1099-5129
Impact factor: 4.021
 
Signal-Averaged Electrocardiography as a Noninvasive Tool for Evaluating the Outcomes After Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic Heart Disease: Reassessment of an Old Tool.
Dinov B, Bode K, Koenig S, Oebel S, Sommer P, Bollmann A, Hindricks G, Arya A
Circ Arrhythm Electrophysiol 2016; 9(9): e003673
ISSN 1941-3149
Impact factor: 4.428
 
Patterns of left atrial activation and evaluation of atrial dyssynchrony in patients with atrial fibrillation and normal controls: Factors beyond the left atrial dimensions.
Dinov B, Knopp H, Lobe S, Nedios S, Bode K, Schonbauer R, Sommer P, Bollmann A, Arya A, Hindricks G
Heart Rhythm 2016; 13(9): 1829-1836
ISSN 1547-5271
Impact factor: 4.391
 
Long-Term Impact of Right Ventricular Pacing on Left Ventricular Systolic Function in Pacemaker Recipients With Preserved Ejection Fraction: Results From a Large Single-Center Registry.
Ebert M, Jander N, Minners J, Blum T, Doering M, Bollmann A, Hindricks G, Arentz T, Kalusche D, Richter S
J Am Heart Assoc 2016; 5(7): e003485
ISSN 2047-9980
Impact factor: 5.117
 
Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial.
Fengler K, Heinemann D, Okon T, Rohnert K, Stiermaier T, von Roder M, Besler C, Muller U, Hollriegel R, Schuler G, Desch S, Lurz P
Clin Res Cardiol 2016; 105(7): 592-600
ISSN 1861-0684
Impact factor: 4.324
 
Renal sympathetic denervation in therapy resistant hypertension - pathophysiological aspects and predictors for treatment success.
Fengler K, Rommel KP, Okon T, Schuler G, Lurz P
World J Cardiol 2016; 8(8): 436-446
ISSN 1949-8462
Impact factor: 0.000
 
[Implantable loop recorder in atrial fibrillation and after catheter ablation].
Fikenzer K, Dagres N, Hindricks G
Herzschrittmacherther Elektrophysiol 2016; 27(4): 355-359
ISSN 0938-7412
Impact factor: 0.000
 
Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial.
Haussig S, Mangner N, Dwyer MG, Lehmkuhl L, Lucke C, Woitek F, Holzhey DM, Mohr FW, Gutberlet M, Zivadinov R, Schuler G, Linke A
JAMA 2016; 316(6): 592-601
ISSN 0098-7484
Impact factor: 37.684
 
Real-time magnetic resonance-guided ablation of typical right atrial flutter using a combination of active catheter tracking and passive catheter visualization in man: initial results from a consecutive patient series.
Hilbert S, Sommer P, Gutberlet M, Gaspar T, Foldyna B, Piorkowski C, Weiss S, Lloyd T, Schnackenburg B, Krueger S, Fleiter C, Paetsch I, Jahnke C, Hindricks G, Grothoff M
Europace 2016; 18(4): 572-577
ISSN 1099-5129
Impact factor: 4.021
 
Remote monitoring and heart failure: monitoring parameters, technology, and workflow. Editorial.
Hindricks G, Varma N
Eur Heart J 2016; 37(41): 3164-3166
ISSN 0195-668X
Impact factor: 15.064
 
Long-Term Exercise Training in Patients With Advanced Chronic Heart Failure: SUSTAINED BENEFITS ON LEFT VENTRICULAR PERFORMANCE AND EXERCISE CAPACITY.
Hollriegel R, Winzer EB, Linke A, Adams V, Mangner N, Sandri M, Bowen TS, Hambrecht R, Schuler G, Erbs S
J Cardiopulm Rehabil Prev 2016; 36(2): 117-124
ISSN 1932-7501
Impact factor: 1.632
 
Hemodynamic Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement: The Diastolic Pressure-Time Index.
Hollriegel R, Woitek F, Stativa R, Mangner N, Haussig S, Fuernau G, Holzhey D, Mohr FW, Schuler GC, Linke A
JACC Cardiovasc Interv 2016; 9(10): 1061-1068
ISSN 1936-8798
Impact factor: 7.630
 
Genomic Contributors to Rhythm Outcome of Atrial Fibrillation Catheter Ablation - Pathway Enrichment Analysis of GWAS Data.
Husser D, Buttner P, Ueberham L, Dinov B, Sommer P, Arya A, Hindricks G, Bollmann A
PLoS One 2016; 11(11): e0167008
ISSN 1932-6203
Impact factor: 3.057
 
Genomic contributors to atrial electroanatomical remodeling and atrial fibrillation progression: Pathway enrichment analysis of GWAS data.
Husser D, Ueberham L, Dinov B, Kosiuk J, Kornej J, Hindricks G, Shoemaker MB, Roden DM, Bollmann A, Buttner P
Sci Rep 2016; 6: 36630
ISSN 2045-2322
Impact factor: 5.228
 
[2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS].
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P
Kardiol Pol 2016; 74(12): 1359-1469
ISSN 0022-9032
Impact factor: 0.878
 
Accessory pathway ablation in childhood forming the substrate for ventricular tachycardia in adulthood.
Koch J, Lucke C, Gebauer R, Hindricks G, Arya A
Eur Heart J 2016; 37(7): 609-10
ISSN 0195-668X
Impact factor: 15.064
 
Addition of TGF-ß1 to existing clinical risk scores does not improve prediction for arrhythmia recurrences after catheter ablation of atrial fibrillation.
Kornej J, Ueberham L, Schmidl J, Husser D, Adams V, Hindricks G, Bollmann A
Int J Cardiol 2016; 221: 52-54
ISSN 0167-5273
Impact factor: 4.638
 
Channel-Based Gap Mapping for Pulmonary Vein Isolation.
Kosiuk J, Hilbert S, Hindricks G, Bollmann A
J Cardiovasc Electrophysiol 2016; 27(4): 488-489
ISSN 1045-3873
Impact factor: 3.097
 
Letter from Kosiuk et al Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
Kosiuk J, Hindricks G, Bollmann A
Circulation 2016; 134(10): 183-184
ISSN 0009-7322
Impact factor: 17.202
 
Need for further studies on ivabradine in patients with persistent atrial fibrillation.
Kosiuk J, Lindemann F, Hindricks G, Bollmann A
Int J Cardiol 2016; 223: 915-916
ISSN 0167-5273
Impact factor: 4.638
 
Termination of the left atrial tachycardia by the ablation of epicardial critical isthmus visualized with a novel high-resolution mapping system.
Kosiuk J, Lindemann F, Hindricks G, Bollmann A
Clin Res Cardiol 2016; 105(12): 1049-1050
ISSN 1861-0684
Impact factor: 4.324
 
Effect of remote ischemic preconditioning on electrophysiological and biomolecular parameters in nonvalvular paroxysmal atrial fibrillation (RIPPAF study): Rationale and study design of a randomized, controlled clinical trial.
Kosiuk J, Milani R, Ueberham L, Uhe T, Stegmann C, Hindricks G, Bollmann A
Clin Cardiol 2016; 39(11): 631-635
ISSN 0160-9289
Impact factor: 2.431
 
Long-term adherence to dronedarone in patients with atrial arrhythmias.
Lobe S, John S, Kornej J, Hindricks G, Bollmann A, Husser D
Int J Cardiol 2016; 222: 676-677
ISSN 0167-5273
Impact factor: 4.638
 
A Prima Vista Ablation of Ventricular Tachycardia: Should We Abandon the Mapping of VT?
Lurz JA, Arya A, Hindricks G, Dinov B
J Am Coll Cardiol 2016; 68(6): 669-670
ISSN 0735-1097
Impact factor: 17.759
 
Early experience of the trialign system for catheter-based treatment of severe tricuspid regurgitation.
Lurz P, Besler C, Kiefer P, Ender J, Seeburger J
Eur Heart J 2016; 37(47): 3543-3543
ISSN 0195-668X
Impact factor: 15.064
 
Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial.
Lurz P, Luecke C, Eitel I, Fohrenbach F, Frank C, Grothoff M, de Waha S, Rommel KP, Lurz JA, Klingel K, Kandolf R, Schuler G, Thiele H, Gutberlet M
J Am Coll Cardiol 2016; 67(15): 1800-1811
ISSN 0735-1097
Impact factor: 17.759
 
Reply: T1 and T2 Mapping in Nonischemic Cardiomyopathies and Agreement With Endomyocardial Biopsy.
Lurz P, Luecke C, Klingel K, Thiele H, Gutberlet M
J Am Coll Cardiol 2016; 68(17): 1925
ISSN 0735-1097
Impact factor: 17.759
 
Renal sympathetic denervation in uncontrolled arterial hypertension after successful repair for aortic coarctation.
Lurz P, Okon T, Riede T, Wagner R, Schuler G, Daehnert I, Desch S
Int J Cardiol 2016; 202: 322-327
ISSN 0167-5273
Impact factor: 4.638
 
Reply: Nondilated Left Ventricle as an Adding Clue Helping Discrimination Between Acute Myocarditis From Other Cardiomyopathies.
Lurz P, Rommel KP, Luecke C, Thiele H, Gutberlet M
J Am Coll Cardiol 2016; 68(16): 1818-1819
ISSN 0735-1097
Impact factor: 17.759
 
Comparison of Percutaneous Closure Versus Surgical Femoral Cutdown for Decannulation of Large-Sized Arterial and Venous Access Sites in Adults After Successful Weaning of Veno-Arterial Extracorporeal Membrane Oxygenation.
Majunke N, Mangner N, Linke A, Boudriot E, Erbs S, Tietz F, Wolff S, Schurer S, Schuler G, Sandri M
J Invasive Cardiol 2016; 28(10): 415-419
ISSN 1042-3931
Impact factor: 1.112
 
Exercise Training Prevents Diaphragm Contractile Dysfunction in Heart Failure.
Mangner N, Bowen TS, Werner S, Fischer T, Kullnick Y, Oberbach A, Linke A, Steil L, Schuler G, Adams V
Med Sci Sports Exerc 2016; 48(11): 2118-2124
ISSN 0195-9131
Impact factor: 4.041
 
Incidence, Predictors, and Outcome of Patients Developing Infective Endocarditis Following Transfemoral Transcatheter Aortic Valve Replacement.
Mangner N, Woitek F, Haussig S, Schlotter F, Stachel G, Hollriegel R, Wilde J, Lindner A, Holzhey D, Leontyev S, Mohr FW, Schuler G, Linke A
J Am Coll Cardiol 2016; 67(24): 2907-2908
ISSN 0735-1097
Impact factor: 17.759
 
Coronary Collateral Growth Induced by Physical Exercise: Results of the Impact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable Coronary Artery Disease (EXCITE) Trial.
Mobius-Winkler S, Uhlemann M, Adams V, Sandri M, Erbs S, Lenk K, Mangner N, Mueller U, Adam J, Grunze M, Brunner S, Hilberg T, Mende M, Linke AP, Schuler G
Circulation 2016; 133(15): 1438-48
ISSN 0009-7322
Impact factor: 17.202
 
Long term impact of one daily unit of physical exercise at school on cardiovascular risk factors in school children.
Muller UM, Walther C, Adams V, Mende M, Adam J, Fikenzer K, Machalica KC, Erbs S, Linke A, Schuler G
Eur J Prev Cardiol 2016; 23(13): 1444-1452
ISSN 2047-4873
Impact factor: 3.361
 
Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion.
Mussigbrodt A, John S, Kosiuk J, Richter S, Hindricks G, Bollmann A
Europace 2016; 18(1): 51-56
ISSN 1099-5129
Impact factor: 4.021
 
Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation.
Nedios S, Seewoster T, Lip GH, Husser D, Hindricks G, Bollmann A, Kornej J
Int J Cardiol 2016; 203: 621-623
ISSN 0167-5273
Impact factor: 4.638
 
Invasive aortic pulse wave velocity as a marker for arterial stiffness predicts outcome of renal sympathetic denervation.
Okon T, Rohnert K, Stiermaier T, Rommel KP, Muller U, Fengler K, Schuler G, Desch S, Lurz P
EuroIntervention 2016; 12(5): 684-692
ISSN 1774-024X
Impact factor: 3.863
 
Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.
Raatikainen MJ, Arnar DO, Merkely B, Camm AJ, Hindricks G
Europace 2016; 18(Suppl.3): 1-79
ISSN 1099-5129
Impact factor: 4.021
 
[Current state of treatment strategies for atrial fibrillation].
Rogge C, Hilbert S, Dagres N, Hindricks G
Herz 2016; 41(3): 253-66
ISSN 0340-9937
Impact factor: 0.751
 
Voltage-Based Ablation: The Growing Evidence for the Role of Individually Tailored Substrate Modification for Atrial Fibrillation. Editorial C.
Rolf S, Dagres N, Hindricks G
J Cardiovasc Electrophysiol 2016; 27(1): 31-33
ISSN 1045-3873
Impact factor: 3.097
 
Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
Rommel KP, von Roeder M, Latuscynski K, Oberueck C, Blazek S, Fengler K, Besler C, Sandri M, Lucke C, Gutberlet M, Linke A, Schuler G, Lurz P
J Am Coll Cardiol 2016; 67(15): 1815-1825
ISSN 0735-1097
Impact factor: 17.759
 
Chronic heart failure and aging - effects of exercise training on endothelial function and mechanisms of endothelial regeneration: Results from the Leipzig Exercise Intervention in Chronic heart failure and Aging (LEICA) study.
Sandri M, Viehmann M, Adams V, Rabald K, Mangner N, Hollriegel R, Lurz P, Erbs S, Linke A, Kirsch K, Mobius-Winkler S, Thiery J, Teupser D, Hambrecht R, Schuler G, Gielen S
Eur J Prev Cardiol 2016; 23(4): 349-358
ISSN 2047-4873
Impact factor: 3.361
 
Current controversies in determining the main mechanisms of atrial fibrillation.
Schotten U, Dobrev D, Platonov PG, Kottkamp H, Hindricks G
J Intern Med 2016; 279(5): 428-438
ISSN 0954-6820
Impact factor: 7.803
 
Renal denervation in challenging anatomy: Current strategies and pre-procedural imaging.
Seewoster T, Hilbert S, Rogge C, Paetsch I, Jahnke C, Hindricks G, Bollmann A
Int J Cardiol 2016; 224: 1-3
ISSN 0167-5273
Impact factor: 4.638
 
Skeletal Muscle Alterations Are Exacerbated in Heart Failure With Reduced Compared With Preserved Ejection Fraction: Mediated by Circulating Cytokines?
Seiler M, Bowen TS, Rolim N, Dieterlen MT, Werner S, Hoshi T, Fischer T, Mangner N, Linke A, Schuler G, Halle M, Wisloff U, Adams V
Circ Heart Fail 2016; 9(9): e003027
ISSN 1941-3289
Impact factor: 6.833
 
About Specific Targets and Collateral Damage.
Sommer P, Bollmann A, Hindricks G
J Am Coll Cardiol 2016; 68(3): 283-285
ISSN 0735-1097
Impact factor: 17.759
 
Successful Repeat Catheter Ablation of Recurrent Longstanding Persistent Atrial Fibrillation With Rotor Elimination as the Procedural Endpoint: A Case Series.
Sommer P, Kircher S, Rolf S, John S, Arya A, Dinov B, Richter S, Bollmann A, Hindricks G
J Cardiovasc Electrophysiol 2016; 27(3): 274-280
ISSN 1045-3873
Impact factor: 3.097
 
The year in cardiology 2015: arrhythmias and device therapy.
Steffel J, Jais P, Hindricks G
Eur Heart J 2016; 37(7): 587-593
ISSN 0195-668X
Impact factor: 15.064
 
Endovascular ultrasound for renal sympathetic denervation in patients with therapy-resistant hypertension not responding to radiofrequency renal sympathetic denervation.
Stiermaier T, Okon T, Fengler K, Mueller U, Hoellriegel R, Schuler G, Desch S, Lurz P
EuroIntervention 2016; 12(2): e282-289
ISSN 1774-024X
Impact factor: 3.863
 
Incremental value of Veterans Specific Activity Questionnaire and the YMCA-step test for the assessment of cardiorespiratory fitness in population-based studies.
Teren A, Zachariae S, Beutner F, Ubrich R, Sandri M, Engel C, Loffler M, Gielen S
Eur J Prev Cardiol 2016; 23(11): 1221-1227
ISSN 2047-4873
Impact factor: 3.361
 
The Leipzig Prospective Drug-Eluting Balloon-Registry - Outcome of 484 Consecutive Patients Treated for Coronary In-Stent Restenosis and De Novo Lesions Using Paclitaxel-Coated Balloons.
Uhlemann M, Mobius-Winkler S, Adam J, Erbs S, Mangner N, Sandri M, Boudriot E, Woinke M, Schuler GC, Linke A
Circ J 2016; 80(2): 379-386
ISSN 1346-9843
Impact factor: 4.124
 
Percutaneous closure of an incomplete left atrial appendage closure.
Viehmann M, Dahnert I, Schuler G, Sandri M
Clin Res Cardiol 2016; 105(9): 791-793
ISSN 1861-0684
Impact factor: 4.324
 
Pressure-volume-loop-guided closure of an iatrogenic atrial septal defect for right heart failure following MitraClipTM-implantation.
von Roeder M, Rommel KP, Blazek S, Daehnert I, Lurz P
Eur Heart J 2016; 37(41): 3153
ISSN 0195-668X
Impact factor: 15.064
 
Impact of Lifestyle Intervention on HDL-Induced eNOS Activation and Cholesterol Efflux Capacity in Obese Adolescent.
Wesnigk J, Bruyndonckx L, Hoymans VY, De Guchtenaere A, Fischer T, Schuler G, Vrints CJ, Adams V
Cardiol Res Pract 2016; 2016: 2820432
ISSN 2090-0597
Impact factor: 0.000
 
Impact of Rosuvastatin Treatment on HDL-Induced PKC-ßII and eNOS Phosphorylation in Endothelial Cells and Its Relation to Flow-Mediated Dilatation in Patients with Chronic Heart Failure.
Winzer EB, Gaida P, Hollriegel R, Fischer T, Linke A, Schuler G, Adams V, Erbs S
Cardiol Res Pract 2016; 2016: 4826102
ISSN 2090-0597
Impact factor: 0.000
 
Idiopathic Premature Ventricular Contraction Conducting over a Ventricle Myocardial Extension from the Pulmonary Artery.
Yamasaki H, Bertagnolli L, Hindricks G, Arya A
Pacing Clin Electrophysiol 2016; 39(10): 1159-1163
ISSN 0147-8389
Impact factor: 1.440
 
 
Aktuelles
 
 03.09.2025 -
Kongress-Update ESC 2025
 
 
 15.11.2025 -
33. Leipziger Notfalltag
 
 
Klinik für Kardiologie